Bill & Melinda Gates Foundation

Selected news for the capital firm - Bill & Melinda Gates Foundation, collected since 10/2017. Recent stories appear in The Washington Post and aasciences.africa. This capital firm shares healthcare news with COVID-19, AstraZeneca, Genentech, Food and Drug Administration and dozens of others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
2/23/2021 Stanford ... via our speaker series, and convening our 4th annual Women Leaders in Global Health conference with more than 2,300 people from 50 countries. This year we are going even bigger. With funding from the Bill & Melinda Gates Foundation , WomenLift Health has set ambitious targets: to reach tens of thousands of women and male allies over the course of a decade through a portfolio of interventions that drive change at the ...
2/22/2021 Bill & Melinda Gates Foundation Collaborate With CSIR To Promote Health Research biotecnika.org Bill & Melinda Gates Foundation Collaborate With CSIR To Promote Health Research February 22, 2021 --Sharing is Caring--Gates Foundation-CSIR Collaboration To Promote Health ResearchCSIR (Council of Scientific and Industrial Research) and Bill & Melinda Gates Foundation have signed an MoU (Memorandum of Understanding) to back health research in India. Various technological and scientific collaborations will be initiated to support and promote research conducted and developed in the country. India ...
2/20/2021 The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings Benzinga ... of the week after the company temporarily stalled its gene therapy studies in sickle cell disease.A day after bluebird bio shared the negative tidings, Novartis AG (NYSE: NVS ) announced an agreement with the Bill & Melinda Gates Foundation for funding the development of a single-administration, in-vivo gene therapy to cure sickle cell disease.The week also witnessed the forging of a few alliances and partnerships, a slew of ...
2/20/2021 The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings Business Insider ... of the week after the company temporarily stalled its gene therapy studies in sickle cell disease.A day after bluebird bio shared the negative tidings, Novartis AG (NYSE: NVS ) announced an agreement with the Bill & Melinda Gates Foundation for funding the development of a single-administration, in-vivo gene therapy to cure sickle cell disease.The week also witnessed the forging of a few alliances and partnerships, a slew of ...
2/18/2021 Adjuvant Capital Announces $300 Million Venture Fund Designed to Improve Global Public Health vcaonline.com Venture Capital Database 2021 Now Available! Adjuvant Capital Announces $300 Million Venture Fund Designed to Improve Global Public Health Merck, Novartis, IFC, Bill & Melinda Gates Foundation , Children's Investment Fund Foundation, Dalio Philanthropies, Doris Duke Charitable Foundation, ELMA Investments Ltd., Ford Foundation, MacArthur Foundation, Global Health Investment Corporation, CDC Group, Anthos Fund & Asset Management, and Others Join in Oversubscribed Debut Offering NEW YORK, February 18, 2021-- Adjuvant Capital today announced an ...
2/18/2021 Gates, Merck and Novartis-backed Adjuvant Capital raises $300M for neglected diseases FierceBiotech A major group of pharma and charitable groups have joined forces to raise a $300 million venture round for Adjuvant Capital as it goes after forgotten diseases across the globe.Those big names include Merck, Novartis, IFC, the Bill & Melinda Gates Foundation , the Children's Investment Fund Foundation, Dalio Philanthropies, the Doris Duke Charitable Foundation, ELMA Investments Ltd., the Ford Foundation, the MacArthur Foundation, Global Health Investment Corporation, CDC Group, Anthos ...
2/18/2021 Adjuvant Capital Raises $300 Million Global-Health Venture Fund - WSJ The Wall Street Journal Investors including the Bill & Melinda Gates Foundation have backed a $300 million venture-capital fund seeking to make medical innovations more accessible to people in developing countries.The Gates Foundation has committed $75 million to the debut fund of New York-based Adjuvant Capital, which said it already has tapped the pool to invest in 14 companies targeting conditions such as rabies, yellow fever, herpes and Covid-19. Adjuvant completed ...
2/18/2021 How Will Covax Deliver Covid-19 Vaccines to Poorer Countries? The Wall Street Journal ... to buy doses before they had passed clinical trials and been approved by drug regulators. The money to buy the vaccines has been donated mostly by Western governments and charitable groups, such as the Bill & Melinda Gates Foundation .Who is participating in the WHO program? Covax aims to provide free Covid-19 vaccines to at least 20% of the populations of the world’s 92 poorest countries by the end ...
2/18/2021 How Will Covax Deliver Covid-19 Vaccines to Poorer Countries? rolebuild.com ... to buy doses before they had passed clinical trials and been approved by drug regulators. The money to buy the vaccines has been donated mostly by Western governments and charitable groups, such as the Bill & Melinda Gates Foundation . Who is participating in the WHO program?Covax aims to provide free Covid-19 vaccines to at least 20% of the populations of the world’s 92 poorest countries by the end ...
2/18/2021 Venture Capital: Marquee Investors Put $300M Into Adjuvant Capital For Overlooked Diseases dailyalts.com ... neglected diseases,” announced today its raise of an oversubscribed $300 million fund from big names in pharma and philanthropy. Investors in the new venture fund included Merck (NYSE: MRK), Novartis (SWX: NOVN), IFC, Bill & Melinda Gates Foundation , Children’s Investment Fund Foundation, Dalio Philanthropies, Doris Duke Charitable Foundation, ELMA Investments Ltd., Ford Foundation, MacArthur Foundation, Global Health Investment Corporation, CDC Group, Anthos Fund & Asset Management, and others. ( Fierce Biotech ...
2/18/2021 Adjuvant Capital Announces $300 Million Venture Fund Designed to Improve Global Public Health Business Insider Merck, Novartis, IFC, Bill & Melinda Gates Foundation , Children's Investment Fund Foundation, Dalio Philanthropies, Doris Duke Charitable Foundation, ELMA Investments Ltd., Ford Foundation, MacArthur Foundation, Global Health Investment Corporation, CDC Group, Anthos Fund & Asset Management, and Others Join in Oversubscribed Debut OfferingNEW YORK , Feb. 18, 2021 /PRNewswire/ -- Adjuvant Capital today announced an oversubscribed $300 million fund focused on accelerating the development of medical innovations for historically overlooked public health challenges ...
2/18/2021 Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease modernghana.com 18.02.2021 Health Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease Listen to articleBasel, 17th February – 2021 - Novartis today announced that it has entered into a grant agreement with the Bill & Melinda Gates Foundation. As part of the agreement, the foundation will provide funding support for the discovery and development of a single-administration, in ...
2/18/2021 New $300 Million Venture Fund Spotlights Role Of Women In Venture Capital And Public Health Forbes A U.S.-based venture capital firm, Adjuvant Capital , has just announced a new $300 million fund, counting the Bill & Melinda Gates Foundation among its investors. The fund is focused on accelerating the development of medical innovations to tackle public health challenges, an urgent priority in light of the Covid-19 pandemic. In the venture capital world where only 2.4% of founding VC partners are female, Adjuvant Capital is also co ...
2/17/2021 Novartis, Gates Foundation ally on in vivo sickle cell gene therapy FierceBiotech Novartis is adding sickle cell disease to its gene therapy stable through a partnership with the Bill & Melinda Gates Foundation . The latter will support a research team at the Swiss Pharma dedicated to discovering and developing a one-and-done in vivo treatment that can be given easily to patients all over the world.Caused by a single mutation in the gene that codes for beta-globin, a component of ...
2/17/2021 Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease Yahoo News ... and a holistic approach to diagnosis, treatment, and management of the disease in sub-Saharan AfricaBasel, February 17, 2021 — Novartis today announced that it has entered into a grant agreement with the Bill & Melinda Gates Foundation. As part of the agreement, the foundation will provide funding support for the discovery and development of a single-administration, in vivo gene therapy to cure sickle cell disease (SCD). The project ...
2/17/2021 The Ridgway Record ridgwayrecord.com ... to diagnosis, treatment, and management of the disease in sub-Saharan Africa DESCRIPTION: BASEL, SWITZERLAND, February 17, 2021 /3BL Media/ — Novartis today announced that it has entered into a grant agreement with the Bill & Melinda Gates Foundation . As part of the agreement, the foundation will provide funding support for the discovery and development of a single-administration, in vivo gene therapy to cure sickle cell disease (SCD). The project ...
2/17/2021 Bill Gates Sets Off Backlash After Suggesting Rich Countries Should Eat Only Synthetic Beef yerepouni-news.com Bill Gates Sets Off Backlash After Suggesting Rich Countries Should Eat Only Synthetic Beef February 17, 2021by Arty KatkovBill Gates and his wife Melinda founded the Bill & Melinda Gates Foundation , which specialises in a wide range of public health projects and among other things, climate change research.Billionaire philanthropist Bill Gates has caused quite a stir on Twitter after he said in his new book that rich countries ...
2/15/2021 Novartis and the Bill & Melinda Gates Foundation Collaborate to Discover and Develop an Accessible in Vivo Gene Therapy for Sickle Cell Disease 3blmedia.com Justmeans The largest distribution network for CSR and sustainability news, data, and content. Novartis and the Bill & Melinda Gates Foundation Collaborate to Discover and Develop an Accessible in Vivo Gene Therapy for Sickle Cell Disease Feb 17, 2021 1:15 AM ET Summary: Project brings together Novartis drug discovery and gene therapy expertise and funding support from the Gates Foundation Agreement aims to address disparity in access to treatments and to ...
1/27/2021 Bill Gates Sees 6-8 Month Lag for Poor Countries to Get COVID-19 Shots U.S. News & World Report Bill Gates Sees 6-8 Month Lag for Poor Countries to Get COVID-19 Shots By Reuters , Wire Service Content Jan. 27, 2021 By Reuters , Wire Service Content Jan. 27, 2021, at 3:15 a.m. FILE PHOTO: Bill Gates, Co-Chair of Bill & Melinda Gates Foundation , gestures as he speaks during the World Economic Forum (WEF) annual meeting in Davos, Switzerland January 25, 2018. REUTERS/Denis Balibouse ReutersBy Kate KellandLONDON ...
1/27/2021 'Crazy and evil': Bill Gates surprised by pandemic conspiracies dailymagazine.news DAILY MAGAZINE FILE PHOTO: Outbreak of the coronavirus disease (COVID-19) in Berlin FILE PHOTO: Outbreak of the coronavirus disease (COVID-19) in BerlinRETURN TO POST FILE PHOTO: Bill Gates, Co-Chair of Bill & Melinda Gates Foundation , attends a conversation at the 2019 New Economy Forum in Beijing FILE PHOTO: Bill Gates, Co-Chair of Bill & Melinda Gates Foundation , attends a conversation at the 2019 New Economy Forum in ...